Link accused of letting further middleman chip into Woodford investor savings
ACD transferred eight stakes valued at £150m to Acacia Research last week
ACD transferred eight stakes valued at £150m to Acacia Research last week
|
|
But Woodford Equity Income ACD provides scant detail on when and how much money will be returned to shareholders
|
|
Authorised corporate director’s role in listing unquoted companies in Guernsey brought into the spotlight
|
|
ACD had already halved the weighting in the LF Equity Income fund last week at a 74% loss
|
|
Link Equity Income fund hasn’t signalled how the market sell-off will hit timelines for fund wind down
|
|
Eve Sleep shares are down 99% from IPO price of 101p
|
|
Deteriorating markets and prior funding commitments like Rutherford Health create uphill battle for administrators
|
|
Investors remain in the dark about timelines for the illiquid portfolio
|
|
Current Income Focus pricing effectively targets a yield of 7.5%
|
|
Tony Stenning added to ACD’s fund board
|
|
Schroders, Blackrock and Jupiter have been floated as possible replacements
|
|